Daniel Aletaha

91PUBLICATIONS
256CO-AUTHORS
PharmacogenomicsDisease surveillanceMolecular targetsAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (91)

|Jun 26, 2026
Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials.

|Jun 27, 2025
Collecting patient-reported outcomes via the COTIDIANA smartphone app: a prospective validity study.

Nasim Nakhost Lotfi, Francisco Nunes, Pedro Matias

|Dec 31, 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

Eden Sebbag, Kim Lauper, Juan Molina-Collada

|Nov 13, 2024
Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.

Johanna Elin Gehin, Rolf Anton Klaasen, Eirik Klami Kristianslund

|Oct 25, 2024
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study.

Maya H Buch, Daniel Aletaha, Bernard G Combe

|Oct 25, 2024
Management strategies in rheumatoid arthritis.

Victoria Konzett, Daniel Aletaha

Pageof 16

Frequent Collaborators

24 joint publications

Andreas Kerschbaumer

13 joint publications

Tanja Stamm

13 joint publications

Kevin Winthrop

11 joint publications

Michael Markus Bonelli